Fundz

Medincell Appoints Edna Venneker, MD as Chief Medical Officer

PRIVATESep 01, 2026

Position

Chief Medical Officer

Company

MedinCell

Edna Venneker, MD
MontpellierBiotechnologyHealth CareScience And Engineering

Description

Medincell has announced the appointment of Edna Venneker, MD, as Chief Medical Officer. Venneker brings extensive international experience in drug development to the role.

Quick answer

Medincell Appoints Edna Venneker, MD as Chief Medical Officer (September 1, 2026). MedinCell is based in Montpellier, Occitania, France.

Who is the new Chief Medical Officer at MedinCell?
MedinCell named Edna Venneker, MD Chief Medical Officer, announced September 1, 2026.
What did MedinCell announce on September 1, 2026?
Medincell has announced the appointment of Edna Venneker, MD, as Chief Medical Officer. Venneker brings extensive international experience in drug development to the role.
What does MedinCell do?
MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients...
Where is MedinCell based?
MedinCell is based in Montpellier, Occitania, France.
Which similar companies made leadership changes around the same time?
Northwell Health (September 1, 2026), Psilera (August 27, 2026), Septerna (August 25, 2026) and Emmes (August 25, 2026) also announced leadership changes within 45 days of MedinCell.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at MedinCell, and when

A new leader at MedinCell brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day MedinCell raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MedinCell, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MedinCell. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MedinCell

Location

Montpellier, Occitania, France

About

MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particularly thanks to improved compliance, i.e. compliance with medical prescriptions, and to a significant reduction in the quantity of medication required as part of a one-off or chronic treatment. The BEPO® technology makes it possible to control and guarantee the regular delivery of a drug at the optimal therapeutic dose for several days, weeks or months starting from the subcutaneous or local injection of a simple deposit of a few millimeters, fully bioresorbable. Based in Montpellier, MedinCell currently employs more than 140 people representing over 25 different nationalities.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MedinCell changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

David Heuz
Likely contact at this company
••••••••@••••••••

See David Heuz's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for MedinCell's next move

Learn about Strategic plan

MedinCell changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.